Bactetial Vaginosis. Other specified inflammation of vagina and vulva
Conditions
Interventions
Treatment - Drugs
Metronidazole is the drug of imidazole derivatives. In this study, oral tablets of 250 mg, 4 times daily for 7 days is given
Sponsors
The Shahid Beheshti University of Medical Science & Health Service
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:1- bacterial vaginosis approval based on Amsel's criterias 2-married women aged 18-45 years 3-having one partner 4-absence of pregnancy and breast feeding 5-absence of mensturation at the time of attendance 6-not using vaginal drug, antibiotics and immonosupressive drugs since 14 days before starting the research 7-not having intercourse or using vaginal douche within the last 24 hours 8-absence of other types of candidias and trichmonas vaginitis at the time of study 9-not using alchohol , anticoagulant like comadin and disulfiram 10-absence of any diagnose medical disease such as diabetis , blood dyscrasia , thyroid disorders and liver disease by asking a patient 11-not using IUD. Exclusion criteria: 1-drug intolerancy 2-pregnancy during therapy 3-compulsion to use antibiotics
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bactetial Vaginosis. Timepoint: Before treatment and after treatment. Method of measurement: Observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bactetial Vaginosis treatment. Timepoint: 3-7 days after treatment. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSedigheh Amir Ali Akbari
The Shahid Beheshti University of Medical Science & Health Service
Outcome results
None listed